Q2 2025 Koninklijke Philips NV Earnings Call Transcript
Key Points
- Order intake grew by 6%, building on a 9% increase from the previous year, indicating strong demand across regions.
- Comparable sales increased by 1%, with significant strength in the Personal Health segment.
- Margin expanded by 130 basis points to 12.4%, driven by innovation and productivity measures.
- Strong performance in Diagnosis & Treatment, particularly in Image-Guided Therapy and Precision Diagnosis, with double-digit order growth.
- Successful partnerships and innovations, such as the nationwide agreement with the Indonesian Ministry of Health and the launch of the helium-free BlueSeal MRI system, are contributing to growth.
- Comparable sales in Diagnosis & Treatment and Connected Care segments decreased by 1%, impacted by high comparison bases from previous years.
- China's market remains challenging with subdued consumer sentiment and slow recovery in medical equipment tenders.
- Tariff impacts are expected to be more pronounced in the second half of the year, affecting adjusted EBITA margins.
- Personal Health segment faced a decline in China due to inventory destocking, although this was anticipated.
- The company remains cautious about the evolving consumer dynamics in the US and China, which could impact future performance.
Welcome to the Philips second quarter and semiannual 2025 results conference call on Tuesday, July 29, 2025. During the call hosted by Mr. Roy Jakobs, CEO; and Ms. Charlotte Hanneman, CFO. (Operator Instructions) Please note that this call will be recorded, and a replay will be available on the Investor Relations website of Royal Philips.
I'll now hand the conference over to Ms. Durga Doraisamy, Head of Investor Relations. Please go ahead, ma'am.
Hello, everyone. Welcome to Philips results webcast for the second quarter and half year 2025. I'm here with our CEO, Roy Jakobs; and our CFO, Charlotte Hanneman. The press release and investor presentation can be accessed on our Investor Relations website. The replay and full transcript of this website -- of this webcast will be available on our website after this call concludes. I want to draw your attention to our safe harbor statement on the screen and in the presentation.
I will now hand over to Roy.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
